The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of FGFR alterations with FGFR 1-4 gene expression in TUR biopsies and matched NMP22 urine levels in early bladder cancer of the prospective real world clinico-pathological register trial: BRIDGister.
 
Ralph M. Wirtz
Employment - STRATIFYER Molecular Pathology; STRATIFYER Molecular Pathology
Leadership - STRATIFYER Molecular Pathology
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology
Consulting or Advisory Role - BioNTech (Inst); Janssen Oncology (Inst)
Research Funding - Janssen research & Development (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from BioNTech (Inst); Royalties from Qiagen (Inst)
 
Frank Friedersdorff
No Relationships to Disclose
 
Elke Veltrup
Employment - STRATIFYER Molecular Pathology
 
Ergin Kilic
No Relationships to Disclose
 
Richard Watts
Employment - Qiagen
Leadership - Qiagen
Stock and Other Ownership Interests - Qiagen
Research Funding - Qiagen
 
Ronny Kellner
Employment - Qiagen
 
Roland Hake
No Relationships to Disclose
 
Sebastian Eidt
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology
 
Jenny Roggisch
No Relationships to Disclose
 
Stefan Koch
No Relationships to Disclose
 
Thorsten Ecke
No Relationships to Disclose